Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China · Delayed Price · Currency is CNY 16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST
SHE:002755 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 243.45 | 213.72 | 160.29 | -148.53 | -225.83 | 379.91 |
Depreciation & Amortization | 129.22 | 129.22 | 78.41 | 84.7 | 92.19 | 94.51 |
Other Amortization | 4.77 | 4.77 | 13.77 | 4.85 | 5.67 | 4.15 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.03 | -0.03 | -0.21 | -0.3 |
Asset Writedown & Restructuring Costs | -12.28 | -12.28 | 3.06 | 5.7 | 1.09 | 0.86 |
Loss (Gain) From Sale of Investments | 8.95 | 8.95 | -27.32 | -26.89 | -29.72 | -20.68 |
Provision & Write-off of Bad Debts | - | - | -0.16 | -4.48 | -7.02 | -4.51 |
Other Operating Activities | -27.46 | 1.26 | -26.11 | -52.51 | -13.44 | 4.75 |
Change in Accounts Receivable | 0.97 | 0.97 | -154.15 | 53.45 | 262.97 | 363.45 |
Change in Inventory | 71.01 | 71.01 | -31.38 | -26.41 | -1.79 | 26.89 |
Change in Accounts Payable | 228.03 | 228.03 | 395.15 | 93.18 | -133.44 | -281.03 |
Change in Other Net Operating Assets | 7.14 | 7.14 | -8.32 | -7.34 | -3.61 | 1.92 |
Operating Cash Flow | 652.66 | 651.64 | 411.36 | -26.57 | -52.81 | 567.71 |
Operating Cash Flow Growth | 62.57% | 58.41% | - | - | - | -2.18% |
Capital Expenditures | -296.78 | -143.58 | -230.42 | -129.32 | -150.45 | -133.76 |
Sale of Property, Plant & Equipment | 0.56 | 0.17 | 0.66 | 0.59 | 0.88 | 0.94 |
Divestitures | 0.52 | 0.52 | - | - | - | - |
Investment in Securities | -56 | -321 | 29.47 | 115 | -315 | -438 |
Other Investing Activities | 21.21 | 23.22 | 27.05 | 25.29 | 25.65 | 7.79 |
Investing Cash Flow | -330.48 | -440.67 | -173.24 | 11.56 | -438.92 | -563.02 |
Short-Term Debt Issued | - | - | 101.62 | 154.72 | 45 | - |
Long-Term Debt Issued | - | 47 | - | - | - | - |
Total Debt Issued | 30 | 47 | 101.62 | 154.72 | 45 | - |
Short-Term Debt Repaid | - | - | -54 | -65.72 | - | -20 |
Long-Term Debt Repaid | - | -82 | -3.34 | -3.08 | -2.91 | -2.76 |
Total Debt Repaid | -77 | -82 | -57.34 | -68.8 | -2.91 | -22.76 |
Net Debt Issued (Repaid) | -47 | -35 | 44.27 | 85.92 | 42.09 | -22.76 |
Issuance of Common Stock | - | 30 | - | 206.38 | 127.02 | 0.38 |
Repurchase of Common Stock | - | - | - | - | - | -1.6 |
Common Dividends Paid | -111.26 | -111.47 | -1.16 | -1.12 | -93.19 | -185.76 |
Other Financing Activities | -4.22 | -3.95 | - | - | - | - |
Financing Cash Flow | -162.47 | -120.43 | 43.11 | 291.17 | 75.91 | -209.74 |
Foreign Exchange Rate Adjustments | -1.66 | -0.76 | 3.09 | -1.2 | 15.6 | -0.02 |
Net Cash Flow | 158.04 | 89.79 | 284.32 | 274.97 | -400.22 | -205.07 |
Free Cash Flow | 355.88 | 508.07 | 180.94 | -155.89 | -203.27 | 433.95 |
Free Cash Flow Growth | 81.17% | 180.79% | - | - | - | 13.99% |
Free Cash Flow Margin | 20.31% | 28.56% | 10.18% | -10.80% | -10.85% | 13.97% |
Free Cash Flow Per Share | 0.37 | 0.54 | 0.19 | -0.17 | -0.22 | 0.47 |
Cash Interest Paid | - | - | - | - | - | 0.27 |
Cash Income Tax Paid | 222.02 | 213.04 | 204 | 136.72 | 208.09 | 433.1 |
Levered Free Cash Flow | 254.2 | 484.24 | 311.79 | -83.12 | -101.11 | 263.79 |
Unlevered Free Cash Flow | 254.2 | 484.24 | 313.44 | -81.37 | -99.38 | 266.28 |
Change in Working Capital | 305.98 | 305.98 | 209.37 | 110.63 | 124.45 | 109.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.